Endoscopic Closure Devices

Global Endoscopic Closure Devices Market to Reach US$2.9 Billion by 2030

The global market for Endoscopic Closure Devices estimated at US$1.9 Billion in the year 2024, is expected to reach US$2.9 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2024-2030. Endoscopic Closure Systems, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$765.4 Million by the end of the analysis period. Growth in the Endoscopic Clips segment is estimated at 8.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$516.6 Million While China is Forecast to Grow at 11.9% CAGR

The Endoscopic Closure Devices market in the U.S. is estimated at US$516.6 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$624.5 Million by the year 2030 trailing a CAGR of 11.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.7% and 7.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.0% CAGR.

Global Endoscopic Closure Devices Market – Key Trends & Drivers Summarized

Why Are Endoscopic Closure Devices Becoming the Standard for Minimally Invasive Repairs?
The adoption of endoscopic closure devices has seen a significant upsurge in recent years due to advancements in minimally invasive procedures and the rising complexity of gastrointestinal (GI) interventions. These devices are engineered to provide effective closure of perforations, leaks, fistulas, and resection sites within the GI tract without the need for open surgery. A key technological evolution has been the miniaturization and flexibility of closure instruments, allowing access to difficult anatomical locations such as the duodenum or esophagus while maintaining procedural precision. Clip-based systems, over-the-scope clips (OTSC), and suturing platforms have become widely accepted in both emergency and elective therapeutic endoscopy. These devices can be deployed via standard endoscopes, making them compatible across most interventional suites without requiring infrastructure overhaul.

The technological landscape of closure devices is also expanding with the introduction of integrated endoluminal suturing systems that provide full-thickness closure capabilities. These platforms are gaining favor in procedures such as endoscopic submucosal dissection (ESD), endoscopic mucosal resection (EMR), and bariatric endoscopy, where precision closure post-resection is crucial to avoid complications like bleeding or delayed perforation. Innovations in clip design—including rotatable arms, enhanced gripping strength, and re-openable mechanisms—have also improved procedural control. Manufacturers are incorporating radiopaque markers for better visualization and post-procedural verification under fluoroscopy or X-ray, ensuring secure closure and enhanced patient safety. Such features are reshaping surgeon preference, contributing to increased procedural confidence and reduced conversion to surgical repair.

Which Medical Procedures and Use-Cases Are Driving the Demand Surge?
The utilization of endoscopic closure devices is increasingly being driven by their critical role in advanced therapeutic interventions. In gastrointestinal endoscopy, closure devices are vital post-EMR and ESD to prevent delayed bleeding and perforation. With the growing adoption of ESD for early-stage gastrointestinal tumors, especially in Asia and now gradually in Western markets, closure systems are a core component of procedural kits. The demand is also intensifying in colorectal interventions, where large polypectomies often result in mucosal defects that necessitate reliable closure to prevent post-polypectomy syndrome or delayed hemorrhage. Devices tailored to accommodate large luminal diameters and tortuous anatomy are in strong demand, especially in colorectal and bariatric centers.

Beyond oncology and polypectomy applications, closure devices are gaining ground in managing GI leaks and fistulas—conditions previously managed through invasive surgeries or prolonged drainage. For instance, endoscopic management of anastomotic leaks following bariatric surgery or colorectal resections is becoming standard practice in high-volume centers. Transluminal procedures like natural orifice transluminal endoscopic surgery (NOTES) and peroral endoscopic myotomy (POEM) are also creating new demand for high-strength closure tools due to the intentional creation of full-thickness defects. Additionally, trauma care and emergency endoscopy are seeing wider use of closure clips and sutures to manage iatrogenic perforations or bleeding during diagnostic interventions. The expansion of indications from elective to emergent care has firmly embedded these devices into routine clinical workflows.

How Are Regional Ecosystems and Provider Behavior Shaping Adoption?
Regional disparities in healthcare infrastructure, training, and procedural volume significantly affect the adoption curve of endoscopic closure devices. In developed markets such as the United States, Japan, Germany, and South Korea, where GI endoscopy has matured into a subspecialty, closure devices are used extensively in both community and academic settings. Reimbursement clarity from private insurers and national healthcare systems has further enabled widespread adoption. Procedural volume is also boosted by national screening programs for colorectal cancer and gastric malignancies, increasing the incidence of complex resections that require closure. Japan, in particular, leads in procedural innovation and device usage due to its high ESD adoption rates and focus on early detection of GI cancers.

Conversely, in emerging markets such as Brazil, India, and parts of Southeast Asia, adoption is still maturing due to cost constraints, device availability, and limited endoscopist training in therapeutic interventions. However, medical tourism hubs like Thailand and Mexico are rapidly adopting advanced closure systems as they cater to complex gastrointestinal cases from international patients. To bridge gaps, manufacturers are launching region-specific product variants and offering training partnerships with large hospitals and academic institutions. Simultaneously, endoscopist behavior is undergoing a shift, with increasing emphasis on mastering therapeutic and closure techniques. Fellowship programs and global skill-sharing platforms like live endoscopy workshops are playing a crucial role in democratizing access to advanced procedural tools across geographies.

What Factors Are Propelling the Growth Momentum of the Endoscopic Closure Devices Market?
The growth in the global endoscopic closure devices market is driven by several factors that span technological advancements, evolving clinical practices, and the growing complexity of minimally invasive procedures. A primary driver is the sharp increase in gastrointestinal and bariatric endoscopic interventions, many of which require reliable mucosal or transmural closure to avoid serious complications. The global rise in early cancer detection programs, combined with a shift toward endoluminal resection techniques, is expanding the volume of procedures necessitating closure solutions. Moreover, as therapeutic endoscopy becomes a preferred treatment modality for previously surgical indications, closure devices have become indispensable components of the interventional toolkit.

Another growth catalyst is the continual innovation in device design, particularly with the integration of ergonomic handles, precision deployment systems, and materials engineered for high-tensile strength. Manufacturers are also developing hybrid systems that allow both clipping and suturing in a single session, improving procedural efficiency and reducing the need for multiple devices. In parallel, hospital procurement trends are favoring multi-functional platforms and bundled kits that offer value-based solutions to surgical alternatives. Regulatory approvals for new indications and favorable clinical trial outcomes—demonstrating reduced adverse event rates and faster recovery—are reinforcing physician confidence and health system adoption.

Furthermore, the expansion of procedural training and digital simulation tools is reducing the skill barrier associated with device usage, accelerating acceptance among novice and mid-career endoscopists. Medical device companies are investing in comprehensive education programs that pair device deployment with procedural best practices, helping standardize usage across institutions. As cost-effectiveness and patient outcomes become central to hospital decision-making, endoscopic closure devices offer an optimal intersection of safety, speed, and reduced morbidity. These converging trends are expected to sustain the market’s upward trajectory, driving continuous innovation and broader global penetration in the coming years.

SCOPE OF STUDY:

The report analyzes the Endoscopic Closure Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Product Type (Endoscopic Closure Systems, Endoscopic Clips, Overstitch Endoscopic Suturing System, Endoscopic Vacuum-Assisted Closure Systems, Cardiac Septal Defect Occluders, Sealants / Glues, Staplers, Other Product Types); Distribution Channel (Direct Distribution Channel, Indirect Distribution Channel); End-Use (Hospitals End-Use, Ambulatory Surgery Centers End-Use, Clinics End-Use, Other End-Use)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• Abbott Laboratories
• Ackermann Instrumente GmbH
• Apollo Endosurgery, Inc.
• B. Braun Melsungen AG
• Boston Scientific Corporation
• Cardinal Health, Inc.
• CONMED Corporation
• Cook Medical LLC
• CooperSurgical, Inc.
• ENDO-FLEX GmbH
• EndoGastric Solutions, Inc.
• Fujifilm Holdings Corporation
• Johnson & Johnson Services, Inc.
• Karl Storz SE & Co. KG
• Medtronic plc
• Meril Life Sciences Pvt. Ltd.
• Micro-Tech Endoscopy USA, Inc.
• Olympus Corporation
• Ovesco Endoscopy AG
• STERIS plc

AI INTEGRATIONS
We`re transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.